7
Views
0
CrossRef citations to date
0
Altmetric
Anticancers, Hormonals & Metabolic Disease Therapy

Patent Evaluation: Dimeric Vinca Alkaloids that Reverse MDR

Pages 3-4 | Published online: 02 Mar 2011
 

Summary

Novelty: New drug resistance agents are provided which sensitize tumour cells to anticancer drugs and/or inhibit the tumour cells' resistance to antitumour drugs. The agents disclosed can be easily prepared synthetically.

Biology: The compounds consist of a binary vinca alkaloid and have a different absolute configuration to vinblastine or vincristine at C-14′ and/or C-16′. The S absolute configuration in the C-16′ position is essential for antitumour activity. The modulators investigated, specifically C-20′-deoxy-C-20′-diethyl vincovaline, are not cytotoxic at up to 25 μM for sensitive cells and 100 μM for resistant cells.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.